微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 5.94% | 140.49% | 92.23% | 54/158 | 1.25% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 3.09% | 44.39% | 87.27% | 61/158 | 0.28% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 1.65% | 68.37% | -57.14% | 65/158 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 3.85% | 97.44% | 55.87% | 67/158 | -9.6% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 2.47% | 1.65% | 15.42% | 93/158 | 4.24% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 2.14% | 75.41% | 118.37% | 79/158 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 0.98% | 24.05% | -49.74% | 94/158 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 1.95% | -87.42% | -19.75% | 89/158 | -1% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 2.43% | -86.22% | 99.18% | 98/158 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 1.22% | -86.77% | 54.43% | 98/158 | 1.47% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 0.79% | -86.09% | -94.9% | 98/158 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 15.5% | -28.96% | -12.13% | 18/158 | 0.72% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 17.64% | 7.1% | 91.32% | 5/158 | 2.84% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 9.22% | -12.94% | 62.32% | 14/158 | 2.19% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 5.68% | 53.1% | -73.97% | 9/158 | 1.58% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 21.82% | 70.87% | 32.48% | 9/158 | 0.79% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 16.47% | 130.35% | 55.52% | 9/158 | 4.44% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 10.59% | 2% | 185.44% | 14/158 | 2.97% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 3.71% | 827.5% | -70.95% | 27/158 | 2.47% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 12.77% | 55.35% | 78.6% | 38/158 | 3.66% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 7.15% | 2% | 1687.5% | 56/158 | 3.07% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-03-31 | 0.4% | 2% | -95.13% | 76/158 | 2.2% | 河化股份 | 45.32% | 行业排名> |
| 2019-12-31 | 8.22% | 0.61% | 0.61% | 68/158 | 2.57% | 汇宇制药 | 31.9% | 行业排名> |
| 2018-12-31 | 8.17% | -46.32% | -46.32% | 63/158 | 7.17% | 誉衡药业 | 35.56% | 行业排名> |
| 2017-12-31 | 15.22% | 2% | 2% | 24/158 | 9.68% | 奥赛康 | 35% | 行业排名> |